JNJ

238.92

-0.45%↓

UNH

276.74

+0.12%↑

TMO

547.98

+1.1%↑

ABT

110.77

-0.05%↓

ISRG

492.64

+1.1%↑

JNJ

238.92

-0.45%↓

UNH

276.74

+0.12%↑

TMO

547.98

+1.1%↑

ABT

110.77

-0.05%↓

ISRG

492.64

+1.1%↑

JNJ

238.92

-0.45%↓

UNH

276.74

+0.12%↑

TMO

547.98

+1.1%↑

ABT

110.77

-0.05%↓

ISRG

492.64

+1.1%↑

JNJ

238.92

-0.45%↓

UNH

276.74

+0.12%↑

TMO

547.98

+1.1%↑

ABT

110.77

-0.05%↓

ISRG

492.64

+1.1%↑

JNJ

238.92

-0.45%↓

UNH

276.74

+0.12%↑

TMO

547.98

+1.1%↑

ABT

110.77

-0.05%↓

ISRG

492.64

+1.1%↑

Search

Perspective Therapeutics Inc

Atvērts

4.59 -1.29

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

4.35

Max

4.59

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+158.6% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2026. g. 26. marts

Perspective Therapeutics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 8. febr. 23:57 UTC

Tirgus saruna

Uranium Outlook Heats Up on Rising Demand, Uncertain Supply -- Market Talk

2026. g. 8. febr. 23:47 UTC

Tirgus saruna

Gold Rises Amid Growing U.S.-Iran Tensions -- Market Talk

2026. g. 8. febr. 23:43 UTC

Tirgus saruna

Nikkei Likely to Rise Sharply After Takaichi's Election Win -- Market Talk

2026. g. 8. febr. 23:34 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 8. febr. 23:34 UTC

Tirgus saruna

Landslide Election Victory of Japan's LDP Positive for Risk Assets -- Market Talk

2026. g. 8. febr. 23:26 UTC

Tirgus saruna

Yen Skittish; Nikkei Jumps On LDP Landslide -- Market Talk

2026. g. 8. febr. 22:55 UTC

Peļņas

DBS Group 4Q Net S$2.36B Vs. Net S$2.62B >D05.SG

2026. g. 8. febr. 22:55 UTC

Peļņas

DBS Group 4Q Net Interest Income S$3.59B Vs. S$3.83B>D05.SG

2026. g. 8. febr. 22:55 UTC

Peļņas

DBS Board Proposes 4Q Dividend of 66 Singapore Cents/share>D05.SG

2026. g. 8. febr. 22:55 UTC

Peļņas

DBS Group: 2025 Total Dividend at S$3.06/share >D05.SG

2026. g. 8. febr. 22:55 UTC

Peļņas

DBS Group 4Q Net Weighed by Higher Tax Expense, Absence of Non-Recurring Gains Recrorded Last Year >D05.SG

2026. g. 8. febr. 22:55 UTC

Peļņas

DBS Group 4Q Total Income S$5.33B Vs. S$5.51B>D05.SG

2026. g. 8. febr. 21:43 UTC

Tirgus saruna

FX Intervention Watch Resumes After Japan Election Result -- Market Talk

2026. g. 8. febr. 21:16 UTC

Tirgus saruna

Right Of Australian Politics Reshaped as One Nation Surges -- Market Talk

2026. g. 8. febr. 21:15 UTC

Tirgus saruna

Japan's Election Outcome to Revive Takaichi Trade -- Market Talk

2026. g. 7. febr. 09:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 7. febr. 09:20 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 7. febr. 05:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2026. g. 7. febr. 02:46 UTC

Iegādes, apvienošanās, pārņemšana

Big Money, High Anxiety -- Barrons.com

2026. g. 6. febr. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 6. febr. 21:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 6. febr. 21:40 UTC

Iegādes, apvienošanās, pārņemšana

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

2026. g. 6. febr. 21:22 UTC

Tirgus saruna

Mexico's Inflation Seen Accelerating in January -- Market Talk

2026. g. 6. febr. 21:17 UTC

Peļņas

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

2026. g. 6. febr. 21:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2026. g. 6. febr. 21:14 UTC

Iegādes, apvienošanās, pārņemšana

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

2026. g. 6. febr. 21:13 UTC

Peļņas

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

2026. g. 6. febr. 21:13 UTC

Peļņas

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

2026. g. 6. febr. 21:04 UTC

Tirgus saruna

Gold Closes Out Volatile Week on Higher Note -- Market Talk

2026. g. 6. febr. 20:34 UTC

Peļņas

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Perspective Therapeutics Inc Prognoze

Cenas mērķis

By TipRanks

158.6% augšup

Prognoze 12 mēnešiem

Vidējais 12.18 USD  158.6%

Augstākais 18 USD

Zemākais 4 USD

Pamatojoties uz 12 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Perspective Therapeutics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

12 ratings

11

Pirkt

1

Turēt

0

Pārdot

Finanšu rādītāji

$

help-icon Live chat